Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Data re-analysis shows greatest benefit of chemotherapy in ER-negative tumors
December 28th, 2004
Despite the common belief in the oncology community that cancer research and treatment have focused on breast tumors that are estrogen receptor (ER)-positive, a researcher from The University of Texas M.D. Anderson Cancer Center maintains that clinicians have made "enormous strides" in treating patients with tumors that are ER-negative. In a presentation at the annual meeting of the San Antonio Breast Cancer Symposium, Donald Berry, PhD, a professor and chair of the Department of Biostatistics and Applied Mathematics, looked at decades of breast cancer clinical trial experience and found that "the benefit of chemotherapy advances over the last 20 years to ER-negative...
Source: Cancer Weekly (2004-12-28)
|
